The exostosin glycosyltransferase 1/STAT3 axis is a driver of breast cancer aggressiveness
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The epithelial–mesenchymal transition (EMT) program is crucial for transforming carcinoma cells into a partially mesenchymal state, enhancing their chemoresistance, migration, and metastasis. This shift in cell state is tightly regulated by cellular mechanisms that are not yet fully characterized. One intriguing EMT aspect is the rewiring of the proteoglycan landscape, particularly the induction of heparan sulfate proteoglycan (HSPG) biosynthesis. This proteoglycan functions as a co-receptor that accelerates cancer-associated signaling pathways through its negatively-charged residues. However, the precise mechanisms through which EMT governs HSPG biosynthesis and its role in cancer cell plasticity remain elusive. Here, we identified exostosin glycosyltransferase 1 (EXT1), a central enzyme in HSPG biosynthesis, to be selectively upregulated in aggressive tumor subtypes and cancer cell lines, and to function as a key player in breast cancer aggressiveness. Notably, ectopic expression of EXT1 in epithelial cells is sufficient to induce HSPG levels and the expression of known mesenchymal markers, subsequently enhancing EMT features, including cell migration, invasion, and tumor formation. Additionally, EXT1 loss in MDA-MB-231 cells inhibits their aggressiveness-associated traits such as migration, chemoresistance, tumor formation, and metastasis. Our findings reveal that EXT1, through its role in HSPG biosynthesis, governs signal transducer and activator of transcription 3 (STAT3) signaling, a known regulator of cancer cell aggressiveness. Collectively, we present the EXT1/HSPG/STAT3 axis as a central regulator of cancer cell plasticity that directly links proteoglycan synthesis to oncogenic signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1. EXT1 expression and heparan sulfate levels correlate with breast cancer aggressiveness. (A) HSPG levels are upregulated in mesenchymal cell lines. The indicated breast cancer–derived cell lines were subjected to FACS analysis using heparan sulfate-specific 10E4 antibody (Left). The HS median fluorescence intensity was calculated for the epithelial (E) and mesenchymal cell lines (M) (Right); each bar represents the mean ± SD for n = 3. The P-value was determined by Student’s t test. (B) HSPG levels are upregulated in NAMEC vs. HMLE cells. NAMEC is an HMLE-derived cell line that spontaneously acquired the mesenchymal state. The indicated HMLE and NAMEC cell lines were subjected to FACS analysis using the indicated 10E4 antibody (Left). The HS median fluorescence intensity was calculated for the epithelial and mesenchymal cell lines (Right); each bar represents the mean ± SD for n = 5. The P-value was determined by Student’s t test, (C) EXT1 demonstrated elevated expression in mesenchymal cells. Cancer cell lines were divided into epithelial (n = 378 cell lines) and mesenchymal (n = 150 cell lines) groups based on the expression of known mesenchymal markers. The expression of the 10 HS biosynthesis genes was compared with the mean expression in each group. The regression line is presented as a dashed line. (D) The EXT1 protein level is upregulated in mesenchymal breast cancer cell lines. Cells were lysed and subjected to immunoblotting using the indicated antibodies. (E) EXT1 expression is upregulated during the EMT program. HMLE-Twist-ER cells were treated with 4-hydroxytamoxifen (OHT) to induce EMT for 15 d. The cells were collected every 3 d, then lysed and subjected to immunoblotting using the indicated antibodies. N-NAMEC cells. (F) TGFβ1 induces EXT1 expression. HCC1806 cells were treated with 5 ng/mL of TGFβ1 to induce the EMT program for 15 d. Cells were collected and subjected to immunoblotting on each indicated day using the indicated antibodies. (G) EXT1 expression in breast cancer patients correlates with the hallmark of EMT. Breast cancer patients’ gene expression data were generated by the TCGA (PanCancer Atlas project) and analyzed using the cBioPortal web tool (https://www.cbioportal.org). In these samples, the expression of EXT1 was compared to the whole transcriptome (~20,000 genes). The genes were then ranked based on the obtained Spearman’s rank correlation coefficient followed and subjected to gene set enrichment analysis (GSEA). GSEA computed the normalized enrichment score (NES) and false discovery rate (FDR) values. (H) EXT1 expression is elevated in the aggressive breast cancer subtypes. Breast cancer samples were divided into groups based on high and low EXT1 expression (one SD above or below the mean). For each group, the percentage of breast cancer subtypes is color-coded. The breast cancer data was obtained from the METABRIC databases. The cBioPortal calculated the P-values. Lum = luminal. (I) A table reporting the number of human breast cancer samples with “weak,” “moderate,” and “strong” EXT1 staining from triple-negative breast cancer (TNBC) or HER2+, PR-, and ER- (HER2+). Representative staining intensities are shown in images. Magnification, 20×, *P = 0.03 as determined by Fischer’s exact test. (J) EXT1 expression is associated with overall survival (OE), relapse-free survival (RFS), and DM-free survival (DMFS). Kaplan–Meier survival plots for patients with breast cancer were divided into high EXT1 expression [“high” (red)] and low [“low” (black)]. The numbers in parentheses indicate the total number of patients. These plots were generated by the Kaplan–Meier plotter website. The EXT1 (201995_at Affymetrix ID symbol) was used for all the analyses. The number of patients in each study is indicated in parentheses. The hazard ratio (HR) and the log-rank P-value (p) were determined by the analysis tool.](https://figures.cochat.ai/paper-figures/48f616d2a91b4002a133e76b6748fe49/the-exostosin-glycosyltransferase-1-stat3-axis-is-a-driver-of-breast-cancer-figure-1.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When EMT is induced, Snail, ZEB, and Twist repress epithelial gene expression and induce mesenchymal genes ' expression such as EXT1 [35, 36].”
From Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer (2024) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 8×
“GENI performed a Spearman’s rank correlation coefficient analysis between EXT1 expression and the whole transcriptome ( ~ 20,000 genes) of 25 cancer types, followed by gene set enrichment analysis (GSEA) (35).”
MethodInfluentialIntegrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160 · cited 1×
“By analyzing two databases available on the cBioPortal (36), namely the cancer genome atlas (TCGA, PanCancer Atlas project) (37) and the molecular taxonomy of breast cancer international consortium (METABRIC) (38), we found that EXT1 expression is significantly elevated in HER2 and basal compared…”
MethodclusterProfiler 4.0: A universal enrichment tool for interpreting omics data
(2021) · doi:10.1016/j.xinn.2021.100141 · Cited by 12,455
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672 · cited 1×
“We identified that in HMLE cells expressing Twist Family BHLH Transcription Factor 1 (Twist1) conjugated to estrogen receptor (HMLE - Twist - ER) (31), 4 - hydroxytamoxifen (4 - OHT) treatment for 15 d, upregulated EXT1 expression as well as other known mesenchymal markers such as vimentin (VIM)…”
BackgroundThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097 · cited 4×
“By analyzing two databases available on the cBioPortal (36), namely the cancer genome atlas (TCGA, PanCancer Atlas project) (37) and the molecular taxonomy of breast cancer international consortium (METABRIC) (38), we found that EXT1 expression is significantly elevated in HER2 and basal compared to luminal A samples…”
BackgroundInfluentialGyörffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855 · cited 1×
“To rule out any cell - line–specific effects, we stained the immortalized human mammary epithelial (HMLE) cells (26) and their naturally occurring mesenchymal - derived cells (NAMEC) (27) with 10E4.”
BackgroundEMT Transition States during Tumor Progression and Metastasis
Pastushenko, I., & Blanpain, C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.12.001 · Cited by 2,876
Hoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., Shen, R., Taylor, A. M., Cherniack, A. D., Thorsson, V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.022 · Cited by 2,546 · cited 1×
“To whether there is a clinical connection between EXT1 and STAT3 signaling, we analyzed TCGA pan - cancer data (44) and tumor microarrays. we found a significant association between EXT1 expression and IL - 6/JAK/STAT3 signaling ( SI Appendix , Fig.”
BackgroundComprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., Zhang, H., McLellan, M., Yau, C., Kandoth, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.033 · Cited by 1,858 · cited 1×
“By analyzing two databases available on the cBioPortal (36), namely the cancer genome atlas (TCGA, PanCancer Atlas project) (37) and the molecular taxonomy of breast cancer international consortium (METABRIC) (38), we found that EXT1 expression is significantly elevated in HER2 and basal compared…”
MethodRecovering Gene Interactions from Single-Cell Data Using Data Diffusion
van Dijk, D., Sharma, R., Nainys, J., Yim, K., Kathail, P., Carr, A. J., Burdziak, C., Moon, K. R., Chaffer, C. L., Pattabiraman, D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.061 · Cited by 1,829
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797 · cited 1×
“For the lung cancer datasets, we downloaded the samples from GSE49644 (33) and analyzed them using the custom probeset definition used for processing the arrays as defined by Dai et al. (63), so there was one probeset per Entrez Gene ID.”
MethodGyőrffy, B. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.07.014 · Cited by 1,648 · cited 1×
“KM analyses of the breast cancer samples were analyzed and generated by the KM Plotter website (https://kmplot.com/analysis/) (40).”
MethodSarrazin, S., Lamanna, W. C., & Esko, J. D. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004952 · Cited by 1,516 · cited 3×
“The synthesis of HSPGs is a complex and dynamic process orchestrated through a sequence of - reactions (15).”
BackgroundInfluentialOrder Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
CEL-seq2: sensitive highly-multiplexed single-cell RNA-Seq
Hashimshony, T., Senderovich, N., Avital, G., Klochendler, A., de Leeuw, Y., Anavy, L., Gennert, D., Li, S., Livak, K. J., Rozenblatt-Rosen, O., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0938-8 · Cited by 1,125
EMT, MET, Plasticity, and Tumor Metastasis
Bakir, B., Chiarella, A. M., Pitarresi, J. R., & Rustgi, A. K. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.003 · Cited by 1,010 · cited 1×
“These changes involve noticeable alterations in cell morphology, loss of cell–cell interactions (3), acquisition of migratory and invasive capabilities (4), development of chemoresistance (5), and remodeling of the proteoglycan landscape (6).”
BackgroundDynamic EMT: a multi‐tool for tumor progression
Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021) · The EMBO Journal · doi:10.15252/embj.2021108647 · Cited by 761 · cited 1×
“These changes involve noticeable alterations in cell morphology, loss of cell–cell interactions (3), acquisition of migratory and invasive capabilities (4), development of chemoresistance (5), and remodeling of the proteoglycan landscape (6).”
BackgroundA bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Developmental changes in heparan sulfate expression: in situ detection with mAbs.
David, G., Bai, X. M., Van der Schueren, B., Cassiman, J. J., & Van den Berghe, H. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.4.961 · Cited by 477 · cited 2×
“Hence, we stained different breast - cancer - derived cell lines with the specific heparan sulfate antibody (10E4) (25) and found that mesenchymal cell lines (MDA - MB - 231, MDA - MB - 157, and Hs - 578 -”
BackgroundMethodControversies around epithelial–mesenchymal plasticity in cancer metastasis
Williams, E. D., Gao, D., Redfern, A., & Thompson, E. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0213-x · Cited by 451 · cited 1×
“Activation of this program triggers the transdifferentiation of carcinoma cells into a partially mesenchymal state (2), accompanied by profound changes in cellular physiology.”
BackgroundMcCormick, C., Duncan, G., Goutsos, K. T., & Tufaro, F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.668 · Cited by 450 · cited 3×
“EXT1 and EXT2 form a stable complex essential for adding various repeating units of GlcNAc and GlcA to the initial chain (19, 20).”
BackgroundDistinct contributions of partial and full EMT to breast cancer malignancy
Lüönd, F., Sugiyama, N., Bill, R., Bornes, L., Hager, C., Tang, F., Santacroce, N., Beisel, C., Ivanek, R., Bürglin, T., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.11.006 · Cited by 391 · cited 1×
“These changes involve noticeable alterations in cell morphology, loss of cell–cell interactions (3), acquisition of migratory and invasive capabilities (4), development of chemoresistance (5), and remodeling of the proteoglycan landscape (6).”
BackgroundProtein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
Tam, W. L., Lu, H., Buikhuisen, J., Soh, B. S., Lim, E., Reinhardt, F., Wu, Z. J., Krall, J. A., Bierie, B., Guo, W., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.005 · Cited by 321
Heparan Sulfate Biosynthesis: Regulation and Variability
Kreuger, J., & Kjellén, L. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412464972 · Cited by 301
Heparan Sulfate: Biosynthesis, Structure, and Function
(2016) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2016.02.009 · Cited by 298
Ibrahim, S. A., Gadalla, R., El-Ghonaimy, E. A., Samir, O., Mohamed, H. T., Hassan, H., Greve, B., El-Shinawi, M., Mohamed, M. M., & Götte, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0621-z · Cited by 270
Mice deficient in Ext2 lack heparan sulfate and develop exostoses
Stickens, D., Zak, B. M., Rougier, N., Esko, J. D., & Werb, Z. (2005) · Development · doi:10.1242/dev.02088 · Cited by 249 · cited 2×
“HME is a rare skeletal disorder characterized by multiple bony protuberances called exostoses, which can potentially progress into malignant chon-drosarcoma (22, 23).”
BackgroundInfluentialContext specificity of the EMT transcriptional response
Cook, D. P., & Vanderhyden, B. C. (2020) · Nature Communications · doi:10.1038/s41467-020-16066-2 · Cited by 240 · cited 1×
“For the single - cell RNA seq dataset, GSE147405 (64), the imputation of gene expression values was performed using MAGIC (65) before plotting the expression levels of EXT1.”
MethodDihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition
Shaul, Y. D., Freinkman, E., Comb, W. C., Cantor, J. R., Tam, W. L., Thiru, P., Kim, D., Kanarek, N., Pacold, M. E., Chen, W. W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.032 · Cited by 222 · cited 5×
“Previously, we classified cancer cell lines from the MERAV data-base (https://merav.wi.mit.edu/) (29) based on their transcriptomes into epithelial (378 cell lines) and mesenchymal (150 cell lines) (30).”
BackgroundMethodInfluentialSelf-citationPorter, D. E., Lonie, L., Fraser, M., Dobson-Stone, C., Porter, J. R., Monaco, A. P., & Simpson, A. H. R. W. (2004) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.86b7.14815 · Cited by 218 · cited 1×
“Finally, patients with EXT1 mutations and multiple osteochondromas are more prone to malignant transformation than those with EXT2 mutations (51, In study, genetic manipulation techniques established a clear correlation between EXT1 and cancer cell aggressiveness, which was inert for endogenous…”
BackgroundLuo, M., Brooks, M., & Wicha, M. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211120604 · Cited by 215 · cited 1×
“However, challenges such as tumor metastasis and drug resistance continue to hinder effective cancer therapy (1).”
BackgroundContribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation
Busse, M., Feta, A., Presto, J., Wilén, M., Grønning, M., Kjellén, L., & Kusche-Gullberg, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703560200 · Cited by 211 · cited 1×
“EXT1 and EXT2 form a stable complex essential for adding various repeating units of GlcNAc and GlcA to the initial chain (19, 20).”
BackgroundSystematic identification of signaling pathways with potential to confer anticancer drug resistance
Martz, C. A., Ottina, K. A., Singleton, K. R., Jasper, J. S., Wardell, S. E., Peraza-Penton, A., Anderson, G. R., Winter, P. S., Wang, T., Alley, H. M., et al. (2014) · Science Signaling · doi:10.1126/scisignal.aaa1877 · Cited by 191
Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers
Julien, S., Ivetic, A., Grigoriadis, A., QiZe, D., Burford, B., Sproviero, D., Picco, G., Gillett, C., Papp, S. L., Schaffer, L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1139 · Cited by 191 · cited 1×
“Whereas, in breast cancer, upregulation of EXT1 mRNA has been detected in estrogen receptor (ER) - negative cells (55) and proposed as a high - risk predictor for metastasis (56).”
BackgroundGlycosaminoglycan–Protein Interactions: The First Draft of the Glycosaminoglycan Interactome
Vallet, S. D., Clerc, O., & Ricard-Blum, S. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420946403 · Cited by 168 · cited 1×
“The extracellular matrix (ECM) plays a crucial role in cellular interactions and is enriched in proteoglycan (PG) and glycosaminoglycan (GSG), which form a complex network between cells (7).”
BackgroundThe extostosin family: Proteins with many functions
Busse‐Wicher, M., Wicher, K. B., & Kusche‐Gullberg, M. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.10.001 · Cited by 155
Heparan sulfate proteoglycans: a sugar code for vertebrate development?
Poulain, F. E., & Yost, H. J. (2015) · Development · doi:10.1242/dev.098178 · Cited by 139 · cited 1×
“These reactions include chain initiation, elongation, and subsequent modification (16), which occurs within the Golgi apparatus (17).”
BackgroundSun, Y., Daemen, A., Hatzivassiliou, G., Arnott, D., Wilson, C., Zhuang, G., Gao, M., Liu, P., Boudreau, A., Johnson, L., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-20 · Cited by 137 · cited 2×
“For the lung cancer datasets, we downloaded the samples from GSE49644 (33) and analyzed them using the custom probeset definition used for processing the arrays as defined by Dai et al. (63), so there was one probeset per Entrez Gene ID.”
BackgroundMethodCell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer
Hassan, N., Greve, B., Espinoza‐Sánchez, N. A., & Götte, M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109822 · Cited by 135 · cited 11×
“In this study, we introduce the EXT1/HSPG/ JAK/STAT3 axis, which unravels the mechanism through which drives breast cancer cells toward a more aggressive state.”
BackgroundInfluentialMERAV: a tool for comparing gene expression across human tissues and cell types
Shaul, Y. D., Yuan, B., Thiru, P., Nutter-Upham, A., McCallum, S., Lanzkron, C., Bell, G. W., & Sabatini, D. M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1337 · Cited by 128 · cited 1×
“Previously, we classified cancer cell lines from the MERAV data-base (https://merav.wi.mit.edu/) (29) based on their transcriptomes into epithelial (378 cell lines) and mesenchymal (150 cell lines) (30).”
MethodSelf-citationIbrahim, S. A., Hassan, H., Vilardo, L., Kumar, S. K., Kumar, A. V., Kelsch, R., Schneider, C., Kiesel, L., Eich, H. T., Zucchi, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085737 · Cited by 120 · cited 1×
“The syndecan family comprises four members (SDC1 - 4) (8), with syndecan - 1 (SDC1, CD138) expressed in various tissues and tumors, including breast cancers (48).”
BackgroundMesa, R. A. (2010) · PubMed · Cited by 105
Marques, C., Reis, C. A., Vivès, R. R., & Magalhães, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.778752 · Cited by 103 · cited 2×
“HSPGs are structurally comprised of repeating units of glu-cosamine and glucuronic acid (GlcA) (9), which are heavily modified with diverse sulfate groups (11), creating highly negatively - charged structures (10).”
BackgroundHeparan sulfate proteoglycan – A common receptor for diverse cytokines
Xie, M., & Li, J. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.11.022 · Cited by 97 · cited 2×
“Due to their negative charge, the sulfated chains act as co - receptors, enhancing the interactions between ligands and their respective receptors (60).”
BackgroundSyndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins
Ren, Z., van Andel, H., de Lau, W., Hartholt, R. B., Maurice, M. M., Clevers, H., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2018) · Blood · doi:10.1182/blood-2017-07-797050 · Cited by 87 · cited 7×
“Cells were seeded in 6 cm plates, and the next day, prior to experiments, the cells were washed with PBS twice and treated with Heparinase III (10 mU/mL) (6145 - GH - 010, Amsbio) diluted in DMEM or PBS for 1 h at 37 °C.”
BackgroundMethodInfluentialSyndecan-1 facilitates breast cancer metastasis to the brain
Sayyad, M. R., Puchalapalli, M., Vergara, N. G., Wangensteen, S. M., Moore, M., Mu, L., Edwards, C., Anderson, A., Kall, S. L., Sullivan, M. E., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05347-0 · Cited by 86 · cited 1×
“In breast cancers, SDC1 has been implicated in promoting tumor growth, invasion, metastasis, and chemoresistance (12, 49) and is significantly associated with poor patient prognosis (50).”
BackgroundKhatib, A., Solaimuthu, B., Yosef, M. B., Rmaileh, A. A., Tanna, M., Oren, G., Frisch, M. S., Axelrod, J. H., Lichtenstein, M., & Shaul, Y. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010275117 · Cited by 85
Self-citationCheung, P. K., McCormick, C., Crawford, B. E., Esko, J. D., Tufaro, F., & Duncan, G. (2001) · The American Journal of Human Genetics · doi:10.1086/321278 · Cited by 80 · cited 2×
“HME is a rare skeletal disorder characterized by multiple bony protuberances called exostoses, which can potentially progress into malignant chon-drosarcoma (22, 23).”
BackgroundHeparan Sulfate Proteoglycan Signaling in Tumor Microenvironment
Pasquale, V. D., & Pavone, L. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186588 · Cited by 80
Bukowska‐Olech, E., Trzebiatowska, W., Czech, W., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.759129 · Cited by 79
Syndecan-1 (CD138), Carcinomas and EMT
Couchman, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084227 · Cited by 70
Kim, S., Lee, J., Jeon, M., Nam, S. J., & Lee, J. E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.020 · Cited by 64
Exostosin 1 regulates cancer cell stemness in doxorubicin-resistant breast cancer cells
Manandhar, S., Kim, C.-G., Lee, S.-H., Kang, S. H., Basnet, N., & Lee, Y. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19737 · Cited by 64 · cited 1×
“Furthermore, EXT1 expression has been linked to cancer stemness in doxorubicin - resistant MCF - 7 cells (MCF - 7/ADR), where EXT1 promotes cancer stem cell properties (57).”
BackgroundEmbryonic Fibroblasts with a Gene Trap Mutation in Ext1 Produce Short Heparan Sulfate Chains
Yamada, S., Busse, M., Ueno, M., Kelly, O., Skarnes, W. C., Sugahara, K., & Kusche‐Gullberg, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312624200 · Cited by 57 · cited 1×
“Previous studies have demonstrated that reducing EXT1 expression sulfate (HS) (61).”
BackgroundEvaluation of the Anatomic Burden of Patients with Hereditary Multiple Exostoses
Alvarez, C. M., Vera, M. A. D., Heslip, T. R., et al. (2007) · Clinical Orthopaedics and Related Research · doi:10.1097/blo.0b013e3181334b51 · Cited by 53
Taghavi, A., Akbari, M. E., Hashemi-Bahremani, M., Nafissi, N., Khalilnezhad, A., Poorhosseini, S. M., Hashemi‐Gorji, F., & Yassaee, V. R. (2016) · Oncology Letters · doi:10.3892/ol.2016.5218 · Cited by 46 · cited 1×
“Whereas, in breast cancer, upregulation of EXT1 mRNA has been detected in estrogen receptor (ER) - negative cells (55) and proposed as a high - risk predictor for metastasis (56).”
BackgroundHeparan sulfate proteoglycans as targets for cancer therapy: a review
Onyeisi, J. O. S., Ferreira, B. Z. F., Nader, H. B., & Lopes, C. C. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1838034 · Cited by 44 · cited 2×
“HSPGs are structurally comprised of repeating units of glu-cosamine and glucuronic acid (GlcA) (9), which are heavily modified with diverse sulfate groups (11), creating highly negatively - charged structures (10).”
BackgroundQiao, W., Liu, H., Guo, W., Li, P., & Deng, M. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.12.019 · Cited by 31 · cited 1×
“In breast cancers, SDC1 has been implicated in promoting tumor growth, invasion, metastasis, and chemoresistance (12, 49) and is significantly associated with poor patient prognosis (50).”
BackgroundGENI: A web server to identify gene set enrichments in tumor samples
Hayashi, A., Ruppo, S., Heilbrun, E. E., Mazzoni, C., Adar, S., Yassour, M., Rmaileh, A. A., & Shaul, Y. D. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.053 · Cited by 31 · cited 2×
“This analysis was conducted using the GENI web - based tool (https://yoavshaul - lab.shinyapps.io/gsea - geni/) (34).”
MethodSelf-citationDPYSL2 interacts with JAK1 to mediate breast cancer cell migration
Rmaileh, A. A., Solaimuthu, B., Khatib, A., Lavi, S., Tanna, M., Hayashi, A., Yosef, M. B., Lichtenstein, M., Pillar, N., & Shaul, Y. D. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202106078 · Cited by 27
Self-citationProteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness
Karagiorgou, Z., Fountas, P. N., Manou, D., Knutsen, E., & Theocharis, A. D. (2022) · Cancers · doi:10.3390/cancers14215328 · Cited by 26 · cited 2×
“These changes involve noticeable alterations in cell morphology, loss of cell–cell interactions (3), acquisition of migratory and invasive capabilities (4), development of chemoresistance (5), and remodeling of the proteoglycan landscape (6).”
BackgroundDaakour, S., Hajingabo, L. J., Kerselidou, D., Devresse, A., Kettmann, R., Simonis, N., Dequiedt, F., & Twizere, J. (2016) · BMC Cancer · doi:10.1186/s12885-016-2374-2 · Cited by 19
Dong, S., Wu, Y., Yu, S., et al. (2018) · Medicine · doi:10.1097/md.0000000000012625 · Cited by 14 · cited 1×
“In hepatocellular carcinoma, improved disease - free survival is associated with high EXT1 mRNA levels (54).”
BackgroundMonitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Solaimuthu, B., Hayashi, A., Khatib, A., et al. (2021) · Journal of Visualized Experiments · doi:10.3791/63060 · Cited by 5
Self-citationMonitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Solaimuthu, B., Hayashi, A., Khatib, A., et al. (2021) · Journal of Visualized Experiments · doi:10.3791/63060-v · Cited by 3
Self-citation
Cited by
Yoshimura, A., Horinaka, M., Yaoi, T., Ono, H., Itoh, K., Yamada, T., Takayama, K., & Sakai, T. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02727-2 · Cited by 15
The role of ncRNAs and exosomes in the development and progression of endometrial cancer
Niebora, J., Woźniak, S., Domagała, D., Data, K., Farzaneh, M., Zehtabi, M., Dari, M. A. G., Pour, F. K., Bryja, A., Kulus, M., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1418005 · Cited by 11
“Therefore, STAT3 has become a promising marker and potential therapeutic target in various types of cancers, such as lung, prostate, pancreatic, breast, and endometrial cancer (80 – 84).”
BackgroundGao, R., Lou, N., Yang, S., Yang, M., Fan, G., Dai, L., Tang, L. M., Yao, J., Han, X., & Shi, Y. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-0993 · Cited by 11
Yuan, D., Xu, Y., Xue, L., Zhang, W., Gu, L., & Liu, Q. (2024) · Cell Biology International · doi:10.1002/cbin.12210 · Cited by 8
“Additionally, latest reports indicate that the STAT3 signaling axis plays a crucial role in EMT in tumor tissues (Das et al., 2023; Solaimuthu et al., 2024).”
Chen, H., Han, C., & Ha, C. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-05116-w · Cited by 3
“For example, Solaimuthu et al. point out that the expression of EXT1 is upregulated in breast cancer cells, inducing the expression of mesenchymal markers and enhancement of EMT features, which ultimately lead to cell migration, invasion, and tumor formation [13].”
Metadata
- Authors
- Solaimuthu, B., Khatib, A., Tanna, M., Karmi, A., Hayashi, A., Abu Rmaileh, A., Lichtenstein, M., Takoe, S., Jolly, M. K., & Shaul, Y. D.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112001, Israel
- Indian Institute of Science Education and Research Berhampur (IN)
- Indian Institute of Science Bangalore (IN)
- Corresponding author
- Shaul, Yoav David
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2024-01-12
- Volume
- 121
- Issue
- 3
- Pages
- e2316733121-e2316733121
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC10801894
- OpenAlex
- W4390819295
- Semantic Scholar
- c2566880672e24241a4e65093a85fe4da1e79d50
- Cited by
- 8
- References
- 66
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- Israel Science Foundation (299/21, 1816/16)
- Mizutani Foundation for Glycoscience (220087)
- HUJI | Lady Davis Fellowship Trust, Hebrew University of Jerusalem (0)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- EXT1, STAT3 signaling, epithelial-mesenchymal transition, breast cancer aggressiveness, tumor plasticity, chemoresistance, metastasis, cell migration and invasion, MDA-MB-231 cells
- MeSH terms
- Breast Neoplasms, Cell Line, Cell Movement, Female, Humans, Glycosyltransferases, Heparan Sulfate Proteoglycans, Cell Line, Tumor, STAT3 Transcription Factor, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.